Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19
Phase 2
Completed
- Conditions
- Coronavirus InfectionCovid-19SARS-CoV-2
- Interventions
- Drug: Placebo pMDI
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- Verona Pharma Inc
- Target Recruit Count
- 45
- Registration Number
- NCT04527471
- Locations
- 🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States
News
No news found